NICE has recently released guidance on the use of bempedoic acid in lipid modification. This prompted me to look back at the guidance on lipid modification and I came across a useful document from NICE called a ‘Key Therapeutic Topic’.
They are not guidance per se, but outline different medication options and link into other NICE guidance, so they are quite useful. There are plenty of others too.
Given my knowledge of when to add in ezetimibe and the other medications was a bit hazy and given the new guidance on bempedoic acid, I thought it useful to do a bit of a summary on what we should use and when.